Form D · Private Equity Fund

NovaQuest Pharma Opportunities Fund VI, L.P.

Raleigh, NC · CIK 0001944276

Offering snapshot reported Jun 12, 2024 · SEC filing

Reported sold
$90M
Offering amount: $800M
Investors reported
2
Form D · investor count
Minimum accepted
$30M
Reported outside-investor minimum
First sale
Apr 28, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$45M$90MApr 18, 2023Jun 23, 2023: $90,000,000.00Jun 12, 2024: $90,000,000.00Jun 12, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 12, 2024Amendment$90,000,000$0vs Jun 23, 20232SEC filing
Jun 23, 2023Amendment$90,000,000No comparison2SEC filing
Apr 27, 2023AmendmentYet to sellNo comparison0SEC filing
Apr 18, 2023InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$541K (estimated)
Form D file number
021-479248
Item 12 lists certain recipients (UCEA Capital Partners Ltd., James Edward McCaffrey and Innovation Partners, LLC) with whom the Issuer is no longer actively engaged but could still receive fees in connection with future closings of the Issuer.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Cotton Ginsberg Capital Partners Limited12379917
UCEA Capital Partners Ltd.None
James Edward McCaffrey2163581Innovation Partners, LLC · CRD 146344
Innovation Partners, LLC146344
Pimlico Partners FZCONone

Source: Form D, filed Jun 12, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

NOVAQUEST PHARMA OPPORTUNITIES FUND VI, L.P.

Investment adviser: NOVAQUEST CAPITAL MANAGEMENT, L.L.C.

Gross asset value
$73.9M
Beneficial owners
3
ADV minimum commitment
$10M

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator PINNACLE FUND SERVICES VANCOUVER, Canada Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor BDO CAYMAN LTD. GRAND CAYMAN, Cayman Islands
Custodian SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK SANTA CLARA, California, United States Related to adviser: No
Custodian WELLS FARGO BANK, N.A. SAN FRANCISCO, California, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

BDO CAYMAN LTD.
PCAOB 2162

SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK
LEI 0K2D5AK28E3O5CC06E35

WELLS FARGO BANK, N.A.
LEI KB1H1DSPRFMYMCUFXT09

Filing source

Form ADV 2038092 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-4325860423

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ryan Applegate Director
Michael Bologna Director
Ernest Gerald Brown Director
Carl Hellman Director
Patrick Jordan Director
N/A Nq Pof Vi Gp, L.P. Executive
N/A Nq Pof Vi Gp, Ltd. Executive
Hidekazu Tanaka Director
Jonathan E. Tunnicliffe Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
4208 Six Forks Road Suite 920
Raleigh, NC, 27609